Table 2. The results of quality assessment for each guideline.

Authors/Titles	the Score of Each Item (%)						Overall Recommendation
	Scope&Purpose	Stakeholders	Rigor	Clarity	Applicability	Editorial
Marinos CD [18]	52.78	22.22	13.54	52.78	20.83	0.00	weakly recommended
Donofrio PD [19]	61.11	38.89	31.25	55.56	27.08	20.83	weakly recommended
Benatar M [20]	66.67	33.33	18.75	61.11	10.42	29.17	weakly recommended
Adekanye O [21]	66.67	36.11	4.17	50.00	8.33	8.33	weakly recommended
Benatar M [22]	69.44	52.78	32.29	63.89	12.50	41.67	recommended
Consensus of diagnosis and treatment for myasthemia gravis [23]	33.33	19.44	14.58	52.78	12.50	0.00	weakly recommended
Consensus of diagnosis and treatment for myasthemia gravis [24]	27.78	22.22	16.67	41.67	10.42	0.00	not recommended
Gronseth GS [25]	75.00	50.00	83.33	77.78	52.08	45.83	strongly recommended
Elovaara I [26]	77.78	61.11	68.75	77.78	60.42	66.67	strongly recommended
Skeie GO [27]	80.56	72.22	77.08	83.33	68.75	41.67	strongly recommended
Cortese I [28]	72.22	69.44	83.33	83.33	47.92	75.00	strongly recommended
Patwa HS [29]	72.22	66.67	75.00	88.89	43.75	75.00	strongly recommended
AAEM [30]	52.78	13.89	21.88	47.22	14.58	4.17	weakly recommended
Feasby T [31]	77.78	77.78	66.67	77.78	54.17	58.33	strongly recommended
Skeie GO [32]	55.56	44.44	43.75	69.44	37.50	33.33	weakly recommended
Willison HJ [33]	61.11	47.22	29.17	41.67	25.00	4.17	weakly recommended
Bascić-Kes V [34]	47.22	38.89	30.21	58.33	22.92	4.17	weakly recommended